Format

Send to

Choose Destination
Indian J Cancer. 2018 Jul-Sep;55(3):238-241. doi: 10.4103/ijc.IJC_643_17.

Calculation of dose volume parameters and indices in plan evaluation of HDR interstitial brachytherapy by MUPIT in carcinoma cervix.

Author information

1
Department of Radiotherapy, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.

Abstract

BACKGROUND:

Evaluation of a HDR- interstitial brachytherapy plan is a challenging job. Owing to the complexities and diversity of the normalization and optimization techniques involved, a simple objective assessment of these plans is required. This can improve the radiation dose coverage of the tumour with decreased organ toxicity.

AIM:

To study and document the various dose volume indices and parameters required to evaluate a HDR interstitial brachytherapy plan by Volume normalization and graphical optimization using MUPIT (Martinez Universal Perineal Interstitial Template) in patients of carcinoma cervix.

SETTINGS AND DESIGN:

Single arm, retrospective study.

METHODS AND MATERIALS:

35 patients of carcinoma cervix who received EBRT and HDR brachytherapy using MUPIT, were selected. The dose prescribed was 4 Gray/Fraction in four fractions (16Gy/4) treated twice daily, at least 6 hours apart. CTV and OARs were delineated on the axial CT image set. Volume normalization and graphical optimization was done for planning. Coverage Index (CI), Dose homogeneity index (DHI), Overdose index (OI), Dose non-uniformity ratio (DNR), Conformity Index (COIN) and dose volume parameters i.e. D2cc, D1cc, D0.1cc of rectum and bladder were evaluated.

STATISTICAL ANALYSIS:

SPSS version 16 was used.

RESULTS AND CONCLUSION:

CI was 0.95 ± 1.84 which means 95% of the target received 100% of the prescribed dose. The mean COIN was 0.841 ± 0.06 and DHI was 0.502 ± 0.11. D2cc rectum and bladder was 3.40 ± 0.56 and 2.95 ± 0.62 respectively which was within the tolerance limit of this organs. There should be an optimum balance between these indices for improving the quality of the implant and to yield maximum clinical benefit out of it, keeping the dose to the OARs in limit. Dose optimization should be carefully monitered and an institutional protocol should be devised for the acceptability criteria of these plans.

KEYWORDS:

Cervical carcinoma; Martinez Universal Perineal Interstitial Template; dose volume indices; graphical optimization; interstitial brachytherapy; volume normalization

PMID:
30693886
DOI:
10.4103/ijc.IJC_643_17
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center